老年黄斑变性发病机制及相关药物研究进展

　　4 Edward AO,Ritter R III,Abel KJ,et al.Complement factor H polymorphism and age-related macula degeneration.Science,2005;308:421～424

　　5 Haines JL,Hauser MA,Schmidt S,et al.Complement factor H variant increases the risk of age-related macula degeneration.Science,2005;308:319～321

　　6 Albert J Augustin,Indre Offermann.Emerging drugs for age-related macular degeneration.Expert Opin.Emerging Drugs,2006;11(4):725～740

　　7 Leanne B Josefsen,Ross W Boyle.Photodynamic Therapy and the Development of Metal-Based Photosensitisers.Metal-Based Drugs,2008;2008:1～24

　　8 Mennel S,Peter S,Meyer Ch,et al.Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model.Graefes Arch.Clin.Exp.Ophthalmol,2006;244(8):1015～1021

　　9 Chan Wm,Lai Ty,Wong Al,et al.Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration:a comparative study.Br.J.Ophthalmol,2006;90(3):337～341

　　10 M Amir Ahmadi,Jennifer I Lim.Pharmacotherapy of age-related macular degeneration.Expert Opin.Pharmacother,2008;9(17):3045～3052

　　11 Gragoudas Es,Adamis Ap,Cunnigham Et,et al.Pegaptanib for neovascular age～related macular degeneration.N.Engl.J.Med,2004;351(27):2805～2816

　　12 Stephen R.Russell,MD,Henry L,et al.Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration-A Review of Clinical Outcomes.Survey of Ophthalmology,2007;52:S79～S90

　　13 Avery Rl,Pieramici Dj,Rabena MD,et al.Intravitreal bevacizumab (Avastin) for neovascular age～related macular degeneration.Ophthalmology,2006;113(3):363～372

　　14 Hernandez-Pastor LJ,Ortega A,Garcia～Layana A,et al.Ranibizumab for Neovascular Age～Related Macular Degeneration.Am J Health Syst Pharm,2008;65(19):1805～14

　　15 Cuilla Ta,Regillo C,Desai A,et al.A Phase II,multi

上一页  [1] [2] [3] [4] [5] 下一页